Skip to main content
News Directory 3
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Butantan Dengue Vaccine Approved by Anvisa - News Directory 3

Butantan Dengue Vaccine Approved by Anvisa

November 26, 2025 Jennifer Chen Health
News Context
At a glance
  • Glance: Recent approvals and ​data reinforce the growing availability and effectiveness of dengue vaccines.
  • The approval of the Butantan vaccine represents a significant step towards self-sufficiency in vaccine ‍production for Brazil and perhaps other ‍Latin American countries.⁤ The data on Qdenga is...
Original source: news.google.com

“`html



Dengue​ Vaccine Updates​ – Brazil & Global


Dengue Vaccine​ Updates‌ -⁢ Brazil & Global

Table of Contents

  • Dengue Vaccine​ Updates‌ -⁢ Brazil & Global
    • Key Facts
    • vaccine Details
    • Frequently asked Questions (Brazil Focus)

Glance: Recent approvals and ​data reinforce the growing availability and effectiveness of dengue vaccines. Brazil’s Anvisa​ approved the Butantan vaccine, while‍ Qdenga demonstrates long-lasting protection even in those without ‌prior infection. ‍ Questions remain regarding accessibility ‍and suitability for all⁣ age groups.

Key Facts

  • What: multiple dengue vaccines are ​nearing wider availability, including Butantan (Brazil) and Qdenga (globally).
  • Where: Brazil (Butantan approval), Global (Qdenga⁤ data & availability).
  • When: February 2024 (Anvisa approval), ongoing data releases for Qdenga.
  • Why it Matters: Dengue fever is a significant public‌ health​ threat, ‌especially in tropical and ⁤subtropical regions. Vaccines ⁢offer a crucial preventative measure.
  • What’s Next: Rollout of the Butantan vaccine in Brazil, continued monitoring of Qdenga’s effectiveness,‍ and addressing questions about vaccine access⁣ and eligibility.

vaccine Details

Vaccine Name Developer/Manufacturer Type Approval Status ⁢(as ⁢of Feb 2024) Key Features
Butantan Butantan Institute (Brazil) Live attenuated Approved by Anvisa (Brazil) First ​dengue vaccine developed ⁣entirely in Brazil.
Qdenga Takeda Live attenuated Approved​ in Europe, Indonesia, Thailand, ⁤Australia, and⁤ others. Demonstrated‍ long-lasting protection,⁣ effective even ⁣in ⁢those *without* prior dengue infection.

– drjenniferchen

The approval of the Butantan vaccine represents a significant step towards self-sufficiency in vaccine ‍production for Brazil and perhaps other ‍Latin American countries.⁤ The data on Qdenga is particularly encouraging, as previous‌ dengue ​vaccines ​have shown reduced efficacy in individuals without prior‍ exposure to the ‍virus.⁣ However,⁣ equitable access to these vaccines remains a critical challenge, especially in resource-limited settings ​where dengue is most prevalent. Further research is needed ‌to assess long-term protection and potential impacts on‌ dengue​ serotypes.

Frequently asked Questions (Brazil Focus)

  • Is the dengue vaccine free? Availability of‌ free vaccination will depend on ‌public health programs ⁣and government funding.
  • Can⁤ elderly⁣ people take it? ⁤ This requires medical evaluation. Current recommendations may vary based on individual ​health conditions.

sources:

  • Share this:

    • Share on Facebook (Opens in new window) Facebook
    • Share on X (Opens in new window) X

Related

Search:

News Directory 3

ByoDirectory is a comprehensive directory of businesses and services across the United States. Find what you need, when you need it.

Quick Links

  • Disclaimer
  • Terms and Conditions
  • About Us
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Editorial Guidelines
  • Privacy Policy

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

Connect With Us

© 2026 News Directory 3. All rights reserved.

Privacy Policy Terms of Service